O38 Coeliac disease outcomes of budesonide response in adults: COBRA STUDY from the European society for the study of coeliac disease (ESsCD)

Suneil Raju(Sheffield Teaching Hospitals NHS Foundation Trust), D S Sanders(Sheffield Teaching Hospitals NHS Foundation Trust), F. Biagi(University of Pavia), Valerie Byrnes, Nicoletta Nandi(Sheffield Teaching Hospitals NHS Foundation Trust), Shérine Khater(Hôpital Européen Georges-Pompidou), G Madders(University Hospital Galway), Matilde Topa(University of Milan), Federica Branchi(Humboldt-Universität zu Berlin), Chiara Scarcella(University of Pavia), Miguel Debono(Sheffield Teaching Hospitals NHS Foundation Trust), Georgia Malamut(Délégation Paris 5), Francesca Manza(University of Ferrara), Boris Rosenbaum(Assistance Publique – Hôpitaux de Paris), Flora Kokwaro(Sheffield Teaching Hospitals NHS Foundation Trust), Annalisa Schiepatti(University of Pavia), Gerd Bouma(Amsterdam University Medical Centers), Grace Brownlow(Sheffield Teaching Hospitals NHS Foundation Trust), Rosie Flack(Sheffield Teaching Hospitals NHS Foundation Trust), Liam MacManus(Sheffield Teaching Hospitals NHS Foundation Trust), F Zingone(University of Padua), C Cellier(Assistance Publique – Hôpitaux de Paris), Maria Esteve-Comas(Instituto de Salud Carlos III), Alexandre Bai(Assistance Publique – Hôpitaux de Paris), Manjeevan Singh(Sheffield Teaching Hospitals NHS Foundation Trust), Rebecca Stone(Sheffield Teaching Hospitals NHS Foundation Trust), Albert Cardona-Martin(Instituto de Salud Carlos III), Alicia Raybould(Sheffield Teaching Hospitals NHS Foundation Trust), Giusy Memoli(University of Pavia), C Caranfil(University of Padua), Luca Elli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Unknown
June 1, 2026
Cited by 0


Related Papers